Advertisement

Topics

Oxford BioMedica secures commercial supply licence from UK MHRA

05:52 EDT 8 Aug 2017 | Pharmaceutical Business Review

Oxford BioMedica has been granted a Manufacturer/Importer License (MIA) from the UK Medicines and Healthcare products Regulatory Agency (MHRA), to manufacture and distribute lentiviral vector material for commercial supply.

Original Article: Oxford BioMedica secures commercial supply licence from UK MHRA

NEXT ARTICLE

More From BioPortfolio on "Oxford BioMedica secures commercial supply licence from UK MHRA"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...